Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 62.81
-0.79 (-1.24%)
At close: Oct 22, 2025
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 8.26 billion as of October 23, 2025. Its market cap has increased by 149.54% in one year.
Market Cap
8.26B
Enterprise Value
7.96B
Revenue
1.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
62.81
Market Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 8.26B, an increase of 87.70%. That is a compound annual growth rate of 11.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 8.26B | 104.88% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | 9.75B | 169.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 433.54B |
| WuXi AppTec | 291.36B |
| Shenzhen Mindray Bio-Medical Electronics | 270.26B |
| Sichuan Biokin Pharmaceutical | 144.58B |
| Shanghai United Imaging Healthcare | 117.29B |
| Aier Eye Hospital Group | 114.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 112.87B |
| Yunnan Baiyao Group Co.,Ltd | 101.04B |